Pathology and histopathology are pivotal in understanding cancer biology and guiding treatment decisions. Molecular diagnostics, including next-generation sequencing (NGS), identify genetic mutations and biomarkers critical for targeted therapy selection. Digital pathology integrates AI for efficient slide analysis, reducing human error and improving diagnostic accuracy. Research in this area emphasizes the role of molecular profiling in precision oncology and the development of tools for real-time tissue analysis during surgeries. These advancements empower clinicians with actionable insights, driving personalized cancer treatment.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States